Abundance Wealth Counselors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Abundance Wealth Counselors's XBI Position: Q1 2026 in Review
Abundance Wealth Counselors opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q1 2026: 2,761 shares worth $353K. The stake represents 0.05% of the portfolio and ranks #167 among its holdings. This is a return to the name: Abundance Wealth Counselors previously reported a position in XBI as recently as Q2 2025.
Abundance Wealth Counselors first reported a position in XBI in Q1 2021 and has held it in 13 quarters since. The position peaked at $18M in Q3 2024. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Abundance Wealth Counselors held 2,761 shares of State Street SPDR S&P Biotech ETF worth $353K as of Q1 2026.
- State Street SPDR S&P Biotech ETF was a new Abundance Wealth Counselors position in Q1 2026.
- State Street SPDR S&P Biotech ETF made up 0.05% of Abundance Wealth Counselors's portfolio in Q1 2026, its #167 holding.
- Abundance Wealth Counselors first reported a position in State Street SPDR S&P Biotech ETF in Q1 2021 and has held it in 13 quarters since.
- Abundance Wealth Counselors's State Street SPDR S&P Biotech ETF position peaked at $18M in Q3 2024.
- 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Abundance Wealth Counselors's 13F filing for Q1 2026, filed 23 Apr 2026.